:2TRANSCEND FL

Franck Morschhauser1, Saurabh Dahiya2,3, M Lia Palomba4

  • 1Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France. franck.morschhauser@chu-lille.fr.

Nature medicine
|June 3, 2024
PubMed
概括

利索卡巴丁基马拉利乌塞尔 (liso-cel) 在复发性/耐药性卵泡淋巴瘤 (FL) 中显示出高响应率,包括高风险的二线患者. 这种CAR T细胞疗法为那些没有满足需求的人提供了一个有前途的选择.

相关概念视频

Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K